The largest database of trusted experimental protocols

5 protocols using sortilin

1

Immunohistochemical Analysis of Tumor Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Animals were sacrificed after four weeks and tumors were removed. Hematoxylin–eosin (H&E) staining and immunohistochemistry were performed on 4μm serial coronal sections from paraffin-embedded tumors. Tissue sections were prepared as previously described [62 (link)]. Tissue sections were incubated with antibodies against human Ki67 (1/50, Dako), CD31(1/30, Histonova), YKL-40 (1/1000, Abcam), TrkB (1/200, R&D), p75NTR (1/300, Santa Cruz), sortilin (1/1000, BD bioscience) and Oct4 (1/200) according to the manufacturer's instructions (Boster Bioengineering Company Limited). Anti-rabbit (1/1000) and anti-mouse (1/1000) immunoglobulins HRP EnVision™+ system (Dakocytomation, Glostrup) and DAB (DakoCytomation) were used for the staining revelation.
+ Open protocol
+ Expand
2

Antibody Characterization and Experimental Conditions

Check if the same lab product or an alternative is used in the 5 most similar protocols
Monoclonal antibodies were against GPP130 (Linstedt et al., 1997 (link)), myc (Evan et al., 1985 (link); Jesch et al., 2001 (link)), HA (H3663, Clone HA-7; Sigma), giantin (Linstedt and Hauri, 1993 (link)), GFP (SAB2702197, clone GT859; Sigma), sortilin (Cat# 612100, clone 48/Neurotensin; BD Biosciences), and tubulin (T6557, clone GTU-88; Sigma). Polyclonal antibodies were against GPP130 (Puri et al., 2002 (link)), TMEM165 (NBP1-90651; Novus Biologicals), GAPDH (14C10; Cell Signaling Technology), and sortilin (a kind gift from Claus M. Petersen, Aarhus University [ Petersen et al., 1997 (link)]). Secondary antibodies were Alexa 488 anti-mouse (Cat#A28175; Thermo Fisher Scientific), Alexa 488 anti-rabbit (Cat#A27034; Thermo Fisher Scientific), Alexa 555 anti-rabbit (Cat#A27039; Thermo Fisher Scientific), Alexa 555 anti-mouse (Cat#A28180; Thermo Fisher Scientific), and horseradish peroxidase–conjugated goat anti-mouse (Cat#170-6516; Sigma) and goat anti-rabbit antibodies (Cat#170-6515; Sigma). AP12998 was from Clontech (called D/D solubilizer, Cat#635054). Cycloheximide (Cat#C7698) and monensin (Cat#M5273) were from Sigma. ECL blotting substrate (Cat#32209) and MnCl2 (Cat#M87-500) were from Thermo Fisher Scientific.
+ Open protocol
+ Expand
3

Western Blotting of Key Insulin Signaling Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
Whole cell lysates were prepared as previously described [42] (link). For western blot analysis (and other experiments) the following antibodies were used: TUSC5 (Santa Cruz Biotechnology, SC-292062, 1:1000), GLUT4 (Cell Signaling, #2213, 1:1000; Millipore, 07-1404, 1:1000), Akt (Cell Signaling, #9272, 1:1000), phospho-Akt (Cell Signaling, #4056, 1:1000), Sortilin (BD Bioscience, #612100, 1:1000), V5 (Invitrogen, #46-07-05, 1:5000), Cellugyrin (Santa Cruz Biotechnology, SC-68935), c-Myc (Sigma Aldrich, C3956) and γTubulin (Sigma–Aldrich, T6557, 1:6000). Western blot quantification was done using ImageJ software.
+ Open protocol
+ Expand
4

Protein Signaling Pathway Analysis via Western Blotting

Check if the same lab product or an alternative is used in the 5 most similar protocols
Western blotting was performed with specific antibodies against phospho-p38MAPK-T180/Y182 (#4511), or phospho-AKT-T308 (#2965) from Cell Signaling, or phospho-ERK1(T202/Y204)/ERK2(T185/Y187) (R&D AF1018) and ERK1/2 (AF1576) were obtained from R&D. Antibodies against whole form of p38MAPK (#8690), and AKT (#4691) were from Cell Signaling. p75NTR (Santa Cruz, sc-8317) or (Abcam, ab52987). Pro-BDNF antibody was purchased from Alomone (Cat#: ANT-006). Trk-B (#610101) and sortilin (#612101) were from BD company. As loading control β-actin (Sigma-Aldrich A5441) was used. Functional assays were realized with specific antagonistic antibody to block p75NTR (Upstate, clone ME 20.4, cat# 05-446) used at 15 ng/mL.
In some experiments, we used a broad-spectrum inhibitor of matrix metalloproteinases (MMPs) GM6001 (Calbiochem, CAS142880-36-2) (20 μM) to inhibit the cleavage of pro-BNDF in mature BDNF [21 (link)]. In all cases, GM6001 was added to culture media 30 minutes before pro-BDNF treatment.
+ Open protocol
+ Expand
5

Lithium Citrate Modulates p75NTR Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cultured hippocampal neurons were treated with lithium citrate for 30 min followed by a 30-min treatment with proNGF and compared with neurons treated with proNGF alone, lithium citrate alone and untreated control neurons. Cells were harvested in a buffer containing 0.6 M octylglucoside, 10% Triton X-100, 10× TNE with a phosphatase inhibitor cocktail tablet (Roche). Whole-cell lysates were precleared with protein G-Sepharose beads (Pierce) at 4°C for 60 min. The cleared lysates were incubated overnight at 4°C with α-p75NTR (192 IgG, Millipore) followed by a 2-h incubation at 4°C with protein G-Sepharose beads. Finally, the beads were washed five times with the buffer described above, eluted by boiling in loading buffer for SDS-PAGE. Equal amounts of protein were separated by 8% PAGE, transferred to nitrocellulose membranes, and probed for sortilin (diluted 1:500, BD Sciences) and p75NTR (diluted 1:500, Cell Signaling). All Western blot analyses were performed at least three times with samples from independent experiments.
For the in vivo experiments, hippocampi were dissected 3 d after the seizures and homogenized in RIPA buffer. Lysates were cleared with protein G-Sepharose and incubated overnight with anti-sortilin (BD Science), followed by a 2-h incubation with protein G-Sepharose beads. Samples were analyzed by Western blotting for p75NTR (Millipore).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!